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Abstract
For many bioengineered tissues to have practical clinical application, cryopreservation for use on demand is es-
sential. This study examined different thermal histories on warming and short holding periods at different sub-
zero temperatures on subsequent functional recoveries of alginate encapsulated liver spheroids (ELS) for use in a
bioartiﬁcial liver device. This mimicked transport at liquid nitrogen (196C) or dry ice (*80C) temperatures.
Holding at 80C on warming after 196C storage resulted in ELS expressing signiﬁcant ( p < 0.001) damage
compared with direct thaw from liquid nitrogen, with viable cell number falling from 74.0 – 8.4 million viable
cells/mL without 80C storage to 1.9 – 0.6 million viable cells/mL 72 h post-thaw after 8 days storage at
80C. Even 1 day at 80C after 196C storage resulted in lower viability (down 21% 24 h post-thaw), viable
cell count (down 29% 24 h post-thaw), glucose, and alpha-1-fetoprotein production (reduced by 59% and 95%
24 h from 1 day post-thaw, respectively). Storage at80C was determined to be harmful only during the warm-
ing cycle. Chemical measurements of the alginate component of ELS were unchanged by cryogenic exposure in
either condition.
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Introduction
Successful and reliable transportation and distribution
of bioengineered products from point of manufacture
to point of care are essential for clinical application.
Many biological constructs, such as the 2-L bioartiﬁcial
liver (BAL) device being developed by the authors,1 re-
quire storage at cryogenic temperatures (below150C)
for effective delivery and treatment of acute liver fail-
ure. At cryogenic temperatures, samples can be stored
indeﬁnitely2,3 before thawing on demand. Most com-
plicated bioengineered products take several weeks or
months to produce and so just in time manufacture
is not logistically or economically feasible for patient
treatment.
Methods of transportation have wide consequences
for all cryopreserved constructs. Transportation of bio-
logical agents—both bioengineered constructs and di-
rect specimens such as spermatozoa, tissue samples,
and embryos—is an involved issue, but largely can be
categorized into two groups as follows: transport at
liquid or vapor phase nitrogen temperatures using
commercial dry shippers typically between 196C
and 150C, or transport at dry ice temperatures
(*80C).4–7
A dry shipper is a liquid nitrogen storage container,
pre-charged with cryogen, into which samples can be
placed and transported. As the liquid nitrogen is
adsorbed into zeolites, there is little risk of liquid nitro-
gen spillage. Liquid nitrogen is categorized as a danger-
ous product during shipping however, and so transport
can be relatively expensive. Dry shippers have a ﬁnite
transportation window before uncontrolled warming
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occurs since they cannot easily be ‘‘topped up’’ during
transport. Storage and transport with liquid nitrogen
also comes with increased risk of biomass contamina-
tion as liquid nitrogen is routinely nonsterile, although
this risk may be low for the transport stage.8–11
There are many studies where different tissue types
have been transported successfully at liquid nitrogen
temperatures (LN2).
4–6,12,13 In addition, liquid nitrogen
temperatures are essential for vitriﬁed samples, as
transport at 80C (above the glass transition temper-
ature for many common cryoprotectants) would nor-
mally result in the samples devitrifying extracellularly
on warming, inducing signiﬁcant biological injury.
Transport at dry ice temperatures is also used
widely and is cheaper and easier in many practical
senses.5 The setup for short transport is generally
straightforward, and can be as simple as a polystyrene
box ﬁlled with dry ice. This allows for the transport of
large and irregularly shaped samples easily and does
not require the receiver to have liquid nitrogen han-
dling infrastructure. In addition, 80C freezers are
widely available commercially and found routinely
in the majority of potential treatment centers and
so, samples transported on dry ice can be placed in
a suitable freezer on arrival without temperature dis-
ruption for short or longer term storage. This can pro-
vide ﬂexibility for the end user if products cannot be
used on the day of delivery or operations need to be
rescheduled.
In addressing these topics, it has previously been
demonstrated by our group that encapsulated liver
spheroids (ELS) can be stored for at least 1 year at liq-
uid nitrogen temperatures without signiﬁcant loss of
function, while storage at 80C for periods a month
and over shows damage to the cells; this mirrors results
observed with many other cell types, which require liq-
uid nitrogen temperatures for successful long term
storage.10,14
This study examined, from a cryobiological view-
point, which of the two temperatures of likely transpor-
tation in the cryogenic state (80C or 196C) is
optimal for the ELS comprising the BAL device.
Materials and Methods
Pre-cryopreservation culture methods
Cell culture and encapsulation. An immortalized he-
patocyte cell line (HepG2) was cultured in static ﬂasks
(triple layer) for 2 weeks and passaged twice to produce
required cell numbers. These cells were then added to
alginate in aqueous solution, with a ﬁnal concentration
of 2· 106 cells/mL and 1% alginate (w/v). 0.75% glass
beads (w/v) were added to the alginate/cell mix to act
as a buoyancy regulator during ﬂuidization.
This alginate/cell/glass mix was passed through a
geniaLab JetCutter system to produce alginate ELS,
which were cross-linked with 0.204M aqueous cal-
cium. These alginate beads had a diameter of 500 lm
and clusters of spheroids developed in this volume dur-
ing culture. These were then added to a ﬂuidized bed
bioreactor. This culture method has previously been
described in detail.1,14,15
Fluidized bed culture. Approximately, 2 L of the ELS
biomass was added to a ﬂuidized bed bioreactor and
cultured using alpha-modiﬁed Eagle’s medium supple-
mented with 10% (v/v) human plasma (National Blood
Transfusion Service). After 12 days’ culture, the bio-
mass had achieved a sufﬁcient cell density, at which
point samples were removed for cryopreservation.1
Cryopreservation protocols
Cooling protocol. A cryoprotectant mix was pre-
pared and stored at 4C, consisting of 24% v/v dimethyl
sulfoxide (DMSO; Sigma), in University of Wisconsin
Solution (UW; Organ Recovery Systems). One millili-
ter of this solution was added to 1mL of ELS in 2mL
cryovials, resulting in a ﬁnal concentration of 12%
DMSO, 50% ELS, and 38% UW v/v. 0.1% cholesterol
w/v was included as an ice nucleator.15,16
These samples were stored on ice and added to an
EF600 controlled rate freezer. The EF600 was pro-
grammed to cool from 4C to 80C at 0.3C/min.
Upon completion of the cooling proﬁle, samples were
either transferred to liquid nitrogen or stored in a
80C freezer (Sanyo), depending on the condition
being tested.
Thawing protocols
Positive control. In these experiments, the positive
controls were not unfrozen samples, rather it was sam-
ples cryopreserved, stored in, and warmed directly
from liquid nitrogen—the current optimized protocol.
These did not include any 80C hold step, the condi-
tion under review in this set of experiments.
These samples were removed from liquid nitrogen
storage after 14 days and took 330 sec to thaw in a
37C water bath, before the cryoprotectant was re-
moved and samples returned to culture. This rapid
warm from liquid nitrogen is the current optimized
method.15,17
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Samples stored at 80C after liquid nitrogen
storage. To investigate the effects of storage at
80C after liquid nitrogen storage, mimicking warmer
transportation temperatures, samples were placed into
an insulated box at liquid nitrogen temperatures; this
box was then placed into a80C freezer, with the sam-
ples equilibrating to 80C after*1 h.
Samples were thawed rapidly in a 37C water bath
after storage of 1, 4, or 8 days at 80C. The thawing
process took 200 sec from 80C. Upon thawing, the
cryoprotectant was diluted out and the samples returned
to culture.14,15
The total time samples were cryopreserved for 14 days.
Samples stored only at 80C. To explore the impact
of80C storage over the shorter term where the sam-
ple was never exposed to liquid nitrogen temperatures
even during the cooling step, samples were removed
from the EF600 after the cooling proﬁle had reached
80C and stored in a 80C freezer. Samples were
then removed after 1, 4, and 8 days, thawed in 200 sec
in a 37C water bath, and returned to culture.
Removal of cryoprotectant. Upon sample thaw, the
ELS and freezing mix were emptied from the cryovial
into 50mL centrifuge tubes. To the mix, 1mL of
Hanks’ buffered saline solution (HBSS) chilled to 4C
was added. At 1min intervals, 2, 4, 8, 16, and 16mL
were added to the mix that was gently stirred between
steps. The solution was allowed to equilibrate for 5min,
after which the supernatant was removed and the ELS
added to a Rotary Cell Culture System (RCCS; Synthe-
con) culture containing warmed culture medium.18
Post-thaw culture. The samples were added to the
RCCS, which was operated at 37C in a 5% CO2 hu-
midiﬁed incubator and rotated at a rate of 10 rotations/
min. The RCCS produced a microgravity environment
mimicking the ﬂuidized bed bioreactor.18
Samples were removed with a pipette at 24, 48, and
72 h culture intervals for post-thaw assessments to be
carried out.
Post-thaw assessments
Viability assays. A cell membrane viability assay was
carried out using propidium iodide (PI) and ﬂuorescein
diacetate (FDA) staining as previously described. PI
dyes the nucleus of cells with a permeated membrane,
while FDA only stains metabolically active cells. Meas-
urement and quantiﬁcation of ﬂuorescence were car-
ried out using a Nikon Imaging Suite software with a
validated macro.1,15
Cell count techniques. To determine cell counts, liver
cells were liberated from the alginate beads with a
16mM EDTA solution. The cell spheroids were disag-
gregated and then quantiﬁed using a NucleoCounter
device. Cell counts and viabilities were then merged
to give a viable cell number.1,15
Enzyme-linked immunosorbent assay. Protocol ELS
produce alpha-1-fetoprotein (AFP), the level of which
was measured with sandwich enzyme-linked immuno-
sorbent assays (ELISAs) with primary antibody sourced
from Abcam (Cat. No. ab10071) and Abcam supplying
the secondary, HRF-linked antibody (Cat. No. ab10072);
this was quantiﬁed with a standard curve of human
serum-derived AFP (AppliChem; Cat. No. A6935). Data
were normalized to per mL ELS.
Glucose measurements. Glucose levels in the culture
medium were established using an Analox GM7
through enzyme-linked oxygen rate measurements.
Medium samples were removed from culture, frozen
at 20C. On measurement, the samples were thawed
and glucose measured, with calibration and washes car-
ried out using a glucose standard (Analox) and reagent
(Analox GMRD-002A).
Fourier transform infrared spectroscopy. To deter-
mine whether physical changes in the alginate could
be a source of cell death during the cryopreservation,
Fourier transform infrared (FTIR) spectroscopy was
carried out on alginate beads pre- and post-thaw.
Whole alginate beads were washed four times with a
solution containing 1.57mM CaCl2 0.155M NaCl at
pH 7.4, and 50–100 lL of beads were used for spectra
recordings per condition. Mid-IR spectra were
recorded with a Bruker IFS/66S FTIR spectrophotom-
eter ﬁtted with a liquid nitrogen-cooled MCT-B detec-
tor at 4 cm1 resolution. All cited frequencies have an
accuracy of –1 cm1. FTIR spectra were obtained
within the range between 4000 and 850 cm1 during
250 scans. Spectra of alginate beads and CaCl2 solu-
tions were recorded separately for subsequent subtrac-
tion of the CaCl2 solutions from each bead sample’s
spectrum.
Statistics
In all cases, signiﬁcance was determined by use of a
Student’s t-test. Signiﬁcance was observed at p < 0.05,
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p < 0.01, and p < 0.001—the level stated with each
experiment.
Results
Viability and viable cell number
Samples held at 80C (1, 4, or 8 days), following
storage at 196C, have signiﬁcantly worse viability
on thawing compared with a sample thawed directly
from 196C (Fig. 1). This difference is at maximum
at 24 h post-thaw. No signiﬁcant difference was mea-
sured at the 48 and 72 h post-thaw culture time points
for 1 and 4 day holds compared with a direct thaw. In
samples held for either 1 or 4 days at 80C, samples
held at 80C for 8 days after liquid nitrogen storage
did not recover viability by 72 h post-thaw.
Viable cell numbers, which take into account recov-
ered cell counts (i.e., not those destroyed and washed
out from the system after cryopreservation) and viabil-
ities, show that the controls (thawed directly from
196C) were signiﬁcantly better than those held at
any time points at 80C. While those held for 1
and 4 days at 80C show recovery by 48 h post-
thaw, those held for 8 days did not show any recovery
even by 72 h post-thaw.
However, Figure 2 (left) shows that for samples
stored at only 80C, there was no signiﬁcant differ-
ence between storage times of 1–8 days.
To establish if the interruption to the warming cycle
at 80C was a damaging factor to cryopreservation
per se, a separate set of samples stored at 196C
was warmed to 80C and held for a period of either
1 or 4 h. No signiﬁcant difference in viable cell number
was observed between these samples and a set that was
thawed directly from 196C (Fig. 2; right).
Figure 3 shows the differences in warming proﬁles
between samples warmed directly from liquid nitrogen
to thaw compared with those experiencing a hold at
80C. No signiﬁcant difference is seen in warming
between 196C and the hold commencing at 80C,
excluding warming rate differences between these two
conditions as a cause for differences in post-thaw
outcome.
FIG. 1. Viability (top) and viable cell number (bottom) of samples cooled to 196C, warmed to 80C, and
held for stated periods of time. The total time from freezing to thaw was 14 days. Viability and cell count
measurements were made at 24 h (left), 48 h (center), and 72 h (right) post-thaw. Signiﬁcance from a control
that was thawed without stopping at 80C is denoted by #p < 0.05, *p < 0.01, and +p < 0.001. n = 5 – SD.
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FIG. 2. Left: comparing viable cell numbers of samples stored at80C on cooling to liquid nitrogen storage,
but experienced a direct thaw from liquid nitrogen on warming—no signiﬁcant difference is observed
between any of the sets 24 h post thaw indicating that80C storage is not harmful during the cooling proﬁle.
Right: a separate set of samples that was cooled directly to liquid nitrogen temperatures, but stored for either 1
or 4 h at80C on warming and compared with samples cooled and thawed without a stop. No difference was
observed between any of these sets. n = 5 – SD.
FIG. 3. Comparing the difference in warming rates between samples thawed directly from liquid nitrogen
(straight proﬁle), with ones with a hold at 80C. No signiﬁcant difference was observed between either set
below 80C. The warming proﬁle consisted of warming in air to80C, after which direct thaw samples were
placed into a 37C water bath, and samples held at 80C were placed into a 80C freezer before thaw in a
37C water bath. Data are mean of ﬁve measurements per set.
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Glucose consumption
In the 48 h post-thaw, glucose consumption between
sets thawed directly from 196C (positive control)
or stored at either 80C for 1, 4, or 8 days on thaw
was 355 – 12, 144– 53, 197 – 6, and 71– 37lM per
mL ELS per 24 h, respectively. Any storage time at
80C post-LN2 resulted in signiﬁcantly lower glucose
consumption, as is shown in Figure 4.
Protein synthesis by AFP ELISAs
As can be seen from Figure 5, 2 days post-thaw, ELS
that had been stored at 196C and were thawed di-
rectly exhibited an AFP production of 28.1 – 2.7lg of
AFP per mL ELS per 24 h.
The samples held for 1 day at 80C after LN2 stor-
age exhibited signiﬁcantly reduced AFP production
( p < 0.001) with a production of 1.6 – 0.1lg of AFP
per mL ELS per 24 h.
Sets experiencing a 4- or 8-day hold at 80C had
negligible AFP production. As AFP is unstable in vitro,
very low values may indicate residual AFP in the cul-
ture medium as degrading, with no new AFP produc-
tion detected.19
While the HepG2 cell line used in ELS produces clin-
ically relevant proteins such as albumin, ﬁbrinogen,
and alpha-1-antitrypsin, these are all present normally
in large quantities in human blood plasma. As the cul-
ture media contained 10% human blood plasma, levels
of these proteins cannot easily be observed above back-
ground levels.1,15 AFP is not present in normal human
plasma and is in this study used as a surrogate for clin-
ically relevant protein synthetic activity.1
Chemical assessment of alginate in ELS by FTIR
FTIR spectra of the ELS surface kept for 8 days at
80C (chosen as the time point when signiﬁcant im-
pairment of ELS had been detected, Figs. 1 and 2) and
control beads (thawed rapidly from 196C) show ab-
sorption peaks assignable to calcium alginate at 1600,
1416, 1124, 1090, and 1030 cm1 in Figure 6. Neither
shifts in the absorbance peaks nor changes in absor-
bance ratio relative to the asymmetrical stretching of
the carboxylate peak at 1600 cm1 were seen in ELS
kept at 80C for 8 days with respect to the directly
thawed control. Shoulders near 1650 and 1550 cm1
correspond to the amide I and amide II of the peptide
bonds, respectively, indicating presence of proteins in
both ELS sets.
Discussion
The viable cell number data, Figure 1, show that sam-
ples thawed directly from liquid nitrogen recover
quickly from cryodamage, which can be explained
through cell division and recovery of damage cells.
ELS consume glucose during the metabolic process,
and these data indicate that a direct thaw from
FIG. 4. Glucose consumption levels measured in culture medium 2 days post-thaw of samples experiencing
different lengths of storage at 80C. The samples with no hold consumed signiﬁcantly more glucose than
those experiencing holds of any duration (indicated by *p < 0.001). No signiﬁcant difference was seen between
any of the other sets, n = 5 – SD.
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196C is better for cell recovery. These glucose results
go in line with the observed decrease in viable cell num-
ber.
Nonoptimal warming rates can sometimes be blamed
for poor cryopreservation outcome. This is not the case
in this study–samples held for 1 or 4 h at 80C expe-
rienced the same interruption in cooling rates at
80C, as those with longer holds showed no additional
damage, whereas those with prolonged storage at80C
on thawing did.
Storing the cells isothermally at 80C for 8 days is
no more damaging than for 1 day at 80C following
liquid nitrogen storage (Fig. 2). Previous work has
shown that 1 month storage at 80C (without the
cells experiencing liquid nitrogen temperatures) was
damaging to cells (drop in viable cell number of around
FIG. 5. Alpha-1-fetoprotein (AFP) production per mL ELS per 24 h of samples experiencing different lengths
of hold at80C after196C storage. These measurements were taken at 2 days post-thaw; the samples with
no hold at80C had a signiﬁcantly ( p < 0.001) better AFP production over all other sets. With the exception of
samples held for 1 day at 80C, all samples that experienced a hold at80C on warming had negligible AFP
production, with ND indicating none detected. n = 5 – SD. ELS, encapsulated liver spheroids.
FIG. 6. Absorbance measured between samples experiencing no hold at 80C and samples being held at
80C for 8 days after LN2 storage. Each peak corresponds to chemical bonds, and the lack of any signiﬁcant
difference between the pairs implies no major change in alginate structure as a result of a hold at 80C.
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30%) and 2 months resulted in a fall in viable cell num-
ber of 70% over samples stored below 170C.14 The
present data conﬁrm that damage at 80C increases
nonlinearly with time.
The result that short storage at 80C after liquid
nitrogen storage caused severely reduced post-thaw
function was somewhat surprising and an effect iso-
lated to the warming phase. The glass transition tem-
perature for a 12% DMSO solution is *120C.10,14
Intracellular material typically has a higher glass
transition temperature than the extracellular material
consequent of internal proteins, having a higher vitriﬁ-
cation temperature,20 although its exact value inside
DMSO-permeated mammalian cells is unknown.
The damage is possibly related to the ﬂuidizing of
the freeze concentrated matrix between the ice crys-
tals on rewarming to80C. While ice crystals develop
through our entire system, solutes are preferentially
excluded from this ice front and eventually vitrify in
channels between the ice, and ﬂuidizing of these chan-
nels may stress ELS through chemical or osmotic ef-
fects resulting in poor post-thaw performance. It is
possible that the physical changes that occur when
the extracellular material passes through the glass tran-
sition point impact the cells resulting in a higher sensi-
tivity to damage at 80C when the vitriﬁed channels
reﬂuidize.
Alternatively, thermal stresses may build in the
system due to the large temperature range between
196C and 80C. As samples stored for 8 days have
much lower survival than those stored for 4 days, and
that a 4 h hold at 80C is not problematic, it is
clear that the effect is a longer-term phenomenon,
not an instantaneous or very rapid one. Poorer out-
comes are not observed with a hold of between 1–4 h
on thawing, indicating that the damage is not caused
by having a stop in the thermal proﬁle.
The FTIR data show that there is no change in the
structure of the alginate component of the ELS that
could explain cell death; rather it is a direct effect on
the ELS themselves that is in the origin of the damage.
While storage at 196C is preferable to 80C stor-
age, the data show that damage is not caused by stor-
age only at 80C or transitions between 80C and
196C on the cooling process, rather is an exclusive
factor in the warming proﬁle.
Despite its importance to tissue transport, scant re-
search has been published considering challenges of
transport and resultant variation of storage tempera-
tures. Publications on samples of arterial and heart
valves from the European Homograft Bank state that
these tissues cannot be placed back into liquid nitrogen
after transfer to80C from196C, but can be stored
at 80C for 1–3 months after 196C storage, al-
though damage in this study has been related primarily
to thermal-stress cracking.4,13
One group has reported that in studying transporta-
tion methods with porcine aortic valves, a dry shipper
caused maximal damage and that only dry ice transpor-
tation was possible. However, this was reportedly due to
tissue cracking related to variable warming rates.7 ELS
monitored in this study do not seem susceptible to
major cracking damage, as the liver spheroids are no
larger than about 100lm, and morphology of the ELS
is generally well preserved after cryopreservation.16 In
addition with many grafts, cell survival is not neces-
sary—the scaffold structure is essential and cells can
be reseeded later. Warming rates were shown in this
study not to be a factor in cell death after80C storage.
As more tissue engineered constructs become medi-
cally feasible, problems in addition to thermal cracking,
such as cell function, will become crucial, and this
study helps address those problems. This study shows
that the BAL system requires transport at either
196C or thawed.
Mechanisms have already been developed for
short-term ambient temperature storage21 and post-
vitriﬁcation storage while transporting has also been
reported with mouse embryos.22 However, transport-
ing thawed products can be problematic as recryopre-
serving the device if not used will prove difﬁcult, and
thus, costly products may be wasted.
To summarize, with the current experimental proto-
cols used in this study, ELS should not be transported
and/or stored at 80C after liquid nitrogen storage.
Eight-day storage or transport at 80C after 196C
conditions irreversibly damages the biomass of our
BAL device.
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